Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

QleanAir signs three agreements totaling approximately $1.1 million USD with US healthcare and life science customers, including the 12th cleanroom sold to one customer

QAIRPress release2026-09-29 17:00
Discuss

QleanAir AB (publ), a leading provider of solutions for clean indoor air, has signed three agreements in the United States within a single week, totaling approximately $1.1 million USD. The agreements cover the first cleanroom for a regenerative medicine company within a life science district in Houston, Texas; the 4th cleanroom project for a globally recognized academic health system; and the 12th cleanroom for a state-owned academic health system in the Southeast. Together, the three projects represent approximately 2,700 square feet of cleanroom space, with completion expected between the end of Q4 2026 and the end of Q3 2027.

QleanAir is dedicated to being an excellent partner through building and maintaining modular cleanrooms that exceed USP guidelines and maintain a compliant state of control.

A regenerative medicine company has signed a materials and installation agreement of approximately $479,000 USD for its first QleanAir cleanroom, a 903 square foot suite within a life science district in Houston. The agreement follows a separate design and engineering agreement of approximately $88,000 USD signed in July 2026, bringing the total project value to approximately $567,000 USD. Completion is expected in Q1 2027.

A globally recognized nonprofit academic health system, with 23 hospitals and more than 80,000 caregivers, has signed a design and engineering agreement of approximately $78,000 USD for a 951 square foot cleanroom at one of its hospitals. This is the customer’s 4th QleanAir cleanroom project, and the design phase is expected to be complete by the end of Q4 2026.

A not-for-profit, state-owned academic health system in the Southeast, whose flagship academic medical center is a nationally ranked Level 1 trauma center, has signed an agreement of approximately $545,000 USD for an 837 square foot cleanroom serving its pediatric pharmacy. This is the customer’s 12th QleanAir cleanroom. Its first QleanAir cleanroom turns ten years old this year and remains in operation. Completion is expected by the end of Q3 2027.

“Three agreements in one week, with two long-standing customers and a new partner in Houston’s growing life science community, is a proud moment for our team. When a customer comes back for its 12th cleanroom, it tells us our rooms keep performing year after year. We are grateful for that trust, and we look forward to delivering compliant, dependable cleanrooms on all three projects” says Zachary Douglas, President of QleanAir Scandinavia Inc.

For more information, please contact:


Sebastian Lindström, CEO
sebastian.lindstrom@qleanair.com
+46 703 08 94 51

Fredrik Sandelin, CFO
fredrik.sandelin@qleanair.com
+46 722 09 61 67

About QleanAir


QleanAir is a niche premium provider of clean indoor environment solutions. The company’s business model is based on rental contracts for modular solutions with a full-service offer. QleanAir’s solutions are developed using filter technology that traps, filters and recycles indoor air. The company’s main markets are EMEA, APAC and the Americas. QleanAir’s head office is located in Solna, Sweden, and the share is traded on Nasdaq First North Premier Growth Market, ticker QAIR. FNCA Sweden is Certified Advisor. For more information go to qleanair.com.

Attachments


QleanAir signs three agreements totaling approximately $1.1 million USD with US healthcare and life science customers, including the 12th cleanroom sold to one customer